NAFDAC reforms boost local drug production, attract investors, says DG

NAFDAC says regulatory measures, including ML3 status and the 5+5 Policy, are supporting local pharmaceutical production and attracting foreign investment. The developments concern Nigeria’s healthcare manufacturing environment and may be relevant to investors tracking listed pharmaceutical and healthcare companies on the Nigerian Exchange.